3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
12
Phase 3
2
Phase NA
1
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Multiple Myeloma
11
Neoplasms
8
Vomiting
6
Nausea
5
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Pain, Postoperative
2
Neoplasm, Residual
2
Lymphoma
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Wrist Fractures
1
Systemic Inflammatory Response Syndrome
1
Supratentorial Neoplasms
1
Radicular Cyst
1
Postoperative Nausea and Vomiting
1
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Ovarian Neoplasms
1
Mediastinal Neoplasms
1
Malnutrition
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphohistiocytosis, Hemophagocytic
1
Interventions
Gemcitabine
2
Etoposide
2
Cisplatin
2
ruxolitinib
1
pegaspargase
1
Radiotherapy
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Lenalidomide
1
Drug Therapy
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Lymphoma, Extranodal NK-T-Cell
×
Dexamethasone
×
Clear all
NCT04999878
2021-08-11
RUE-DDGP
Zhengzhou University
Phase 4
Unknown
30 enrolled